Gout Treatment That Decompensates Heart Failure
A 68-year-old woman with heart failure and reduced ejection fraction (LVEF 30%) is stable on enalapril 10 mg twice daily, carvedilol 6.25 mg twice daily, spironolactone 25 mg daily, and furosemide 40 mg daily. She develops an acute gout flare of the right knee. Her family physician prescribes indomethacin 50 mg three times daily. Five days later she presents with increasing dyspnoea, 3 kg weight gain, orthopnoea, and bilateral basal crackles. BP 152/94 mmHg, pulse 96/min, JVP elevated, and there is pitting oedema to mid-shin. Laboratory: creatinine 1.9 mg/dL (baseline 1.1), potassium 5.3 mmol/L, sodium 134 mmol/L. She has no fever, chest pain, or new arrhythmia. She asks why the knee medicine has made her heart failure worse and whether she can continue it until the gout settles. She also wants to know if her regular heart medicines should be changed.
1. Explain the mechanism by which indomethacin precipitated decompensated heart failure and renal dysfunction.
Read the worked answer
In heart failure with reduced ejection fraction, renal perfusion depends heavily on angiotensin II-mediated efferent arteriolar tone and on prostaglandin-mediated afferent arteriolar dilation. The patient is already on an ACE inhibitor and a loop diuretic, so her renal haemodynamics are precariously balanced. Indomethacin inhibits cyclo-oxygenase and removes the prostaglandin-mediated afferent dilation, reducing renal blood flow and glomerular filtration. It also causes sodium and water retention, antagonises the natriuretic effect of furosemide, and raises systemic vascular resistance. The combination produces weight gain, orthopnoea, raised JVP and crackles - the clinical picture of volume overload.
The rising creatinine and potassium reflect both reduced renal perfusion and the interaction of the NSAID with enalapril and spironolactone. Hyperkalemia is particularly likely because ACE inhibition and spironolactone reduce aldosterone effects while the NSAID further suppresses renin-angiotensin-aldosterone activity. This is therefore a predictable pharmacological decompensation, not simply progression of heart failure.
2. What immediate changes to her medication would you make, and how would you treat the gout safely?
Read the worked answer
Stop indomethacin immediately. Treat the congestion with intravenous furosemide 40–80 mg, monitoring urine output, weight, BP and renal function; higher or repeated doses may be needed but should be titrated to response. Temporarily hold enalapril and spironolactone because of the rising creatinine and potassium 5.3 mmol/L; continue carvedilol if she is haemodynamically stable, because abrupt beta-blocker withdrawal can worsen heart failure.
For the gout, avoid systemic NSAIDs. A single intra-articular corticosteroid injection into the knee, after excluding septic arthritis, is effective and has minimal systemic effect. If injection is not feasible, use low-dose oral prednisolone for a short course, or colchicine 0.5 mg once daily with dose adjustment for renal impairment and careful monitoring for diarrhoea and myopathy. Do not start allopurinol during the acute flare without prophylaxis. Recheck potassium and creatinine within 24–48 hours and arrange follow-up for gout prophylaxis once the acute illness resolves.
3. What monitoring and discharge counselling would reduce the risk of recurrence?
Read the worked answer
Record daily weights and provide a written action plan: a weight gain of 2 kg over 2–3 days or increasing breathlessness should prompt early review. Check renal function, potassium and sodium within 3–5 days of discharge and after any diuretic change. Counsel her to avoid all NSAIDs, including over-the-counter ibuprofen and naproxen; paracetamol and topical NSAIDs are preferable, though even topical agents should be used cautiously in heart failure. Provide sick-day rules: during vomiting, diarrhoea or dehydration, contact the team before continuing ACE inhibitors, diuretics and spironolactone.
For gout prevention, arrange urate-lowering therapy with allopurinol after the flare settles, titrated to serum urate, with colchicine or low-dose steroid prophylaxis if renal function allows. Perform medication reconciliation at every visit and document the NSAID-induced decompensation clearly in the record so that future prescribers avoid the same error.